toluene 2,4-diisocyanate has been researched along with guaifenesin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanada, S; Kawai, M; Kohno, S; Nagaya, Y; Nishimura, F; Okamoto, Y; Takeoka, A; Tanaka, K | 1 |
| Cai, SX; Dong, HM; Huang, GH; Xiong, J; Yao, LH; Yu, CH; Zhao, HJ; Zhao, WQ | 1 |
2 other study(ies) available for toluene 2,4-diisocyanate and guaifenesin
| Article | Year |
|---|---|
A nasal allergy model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate.
Topics: Administration, Intranasal; Animals; Cyanates; Disease Models, Animal; Guinea Pigs; Histamine; Male; Mucus; Nasal Mucosa; Passive Cutaneous Anaphylaxis; Rhinitis, Allergic, Perennial; Toluene 2,4-Diisocyanate | 1988 |
[Receptor for advanced glycation end products upregulates MUC5AC expression and promotes mucus overproduction in mice with toluene diisocyanate-induced asthma].
Topics: Animals; Asthma; Benzamides; Butadienes; Extracellular Signal-Regulated MAP Kinases; Mice; Mice, Inbred BALB C; Mucin 5AC; Mucus; Nitriles; Random Allocation; Receptor for Advanced Glycation End Products; Toluene 2,4-Diisocyanate | 2017 |